Valent BioSciences now sells biostimulants directly to U.S. customers
Valent BioSciences established a new operating unit to sell direct in February and it became fully operational on Oct. 1, enabling the organization to serve the entire U.S market. The transition marks a major change in the go-to-market strategy for Valent BioSciences, selling directly to U.S. channel partners.
The new biostimulant business team and salesforce are focused on discovering, developing and commercializing arbuscular mycorrhizal fungi (AMF) products, among other biostimulants, to sustainably maximize retailer and grower profitability.
The core Valent BioSciences biostimulant products are being marketed under the Symvado and Proliant brand names. The team is focused on achieving customer success with biostimulants and will be employing a variety of newly created tools and digital assets to support commercialization of these brands in the U.S. market, according to the release.
“We recognize that biostimulants can be challenging products for customers to successfully utilize, so we are adapting our strategy to best address customer needs and drive value for all parties,” Dave Schumacher, vice president of commercial operations for Valent BioSciences, said in the release.
The new biostimulants business at Valent BioSciences includes numerous technical experts who are available to help retailers and growers navigate this complex market segment.
For more information about Valent BioSciences biostimulant products, please call 877-696-4204 or e-mail biostimulants@valentbiosciences.com.
